Immune inflammation indicators and ALBI score to predict occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals. Issue 1 (February 2018) - Gardini, A.C.; Foschi, F.G.; Conti, F.; Petracci, E.; Marisi, G.; Buonfiglioli, F.; Ravaioli, M.; Mazzella, G.; Muratori, P.; Lenzi, M.; Crespi, C.; Bolondi, L.; et al.